Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT(1)-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertension.
about
Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT(1)-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertension.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Calcium channel blockade in co ...... enal disease and hypertension.
@ast
Calcium channel blockade in co ...... enal disease and hypertension.
@en
Calcium channel blockade in co ...... e inhibition or angiotensin II
@nl
type
label
Calcium channel blockade in co ...... enal disease and hypertension.
@ast
Calcium channel blockade in co ...... enal disease and hypertension.
@en
Calcium channel blockade in co ...... e inhibition or angiotensin II
@nl
prefLabel
Calcium channel blockade in co ...... enal disease and hypertension.
@ast
Calcium channel blockade in co ...... enal disease and hypertension.
@en
Calcium channel blockade in co ...... e inhibition or angiotensin II
@nl
P2860
P356
P1476
Calcium channel blockade in co ...... enal disease and hypertension.
@en
P2093
Bryan Williams
Philip Swales
P2860
P356
10.3317/JRAAS.2002.022
P577
2002-06-01T00:00:00Z